PIK3CD and Hepatitis: The adverse effects of iatrogenic overinhibition of the PI3K pathway not unexpectedly resemble the clinical manifestations of deletion or loss-of-function mutations in PIK3CD described above, specifically enterocolitis and hepatitis [28–32].